CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
1.200
-0.300 (-20.00%)
At close: May 19, 2026, 4:00 PM EDT
1.250
+0.050 (4.17%)
After-hours: May 19, 2026, 7:56 PM EDT
CDT Equity Employees
CDT Equity had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$9,806,000
Market Cap
5.83M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% |
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| HCW Biologics | 36 |
| Bolt Biotherapeutics | 23 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| Immuron | 7 |
| Creative Medical Technology Holdings | 4 |
CDT News
- 12 days ago - CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - GlobeNewsWire
- 12 days ago - CDT Equity announces AZD5904 progresses into patent cooperation treaty phase - TheFly
- 13 days ago - CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - GlobeNewsWire
- 22 days ago - CDT Equity management to meet with Maxim - TheFly
- 27 days ago - CDT Equity files to sell 5.35M shares of common stock for holders - TheFly
- 4 weeks ago - CDT Equity management to meet with Maxim - TheFly
- 4 weeks ago - CDT Equity expands multi-pathway value creation strategy across pharma, IP - TheFly
- 4 weeks ago - CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery - GlobeNewsWire